172 related articles for article (PubMed ID: 886189)
21. [Immune complexes in neoplastic diseases and autoimmune processes].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin complexes in sera of patients with malignancy.
Samayoa EA; McDuffie FC; Nelson AM; Go VL; Luthra HS; Brumfield HW
Int J Cancer; 1977 Jan; 19(1):12-7. PubMed ID: 832917
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
Ruell P; Murray E; McCarthy WH; Hersey P
Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
[TBL] [Abstract][Full Text] [Related]
24. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
25. The immune response and cancer. A guide.
Gilbert HA; Kagan AR
Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
[No Abstract] [Full Text] [Related]
26. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
[TBL] [Abstract][Full Text] [Related]
27. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
28. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
[TBL] [Abstract][Full Text] [Related]
29. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
30. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
31. Immune-complexes in malignant skin melanoma: quantitation by three methods, purification, and characterization of their non-tumor related constituents.
Borzini P; Del Giudice G; Natali S; Serino G; Nembri P; Manca F; Zanussi C
Boll Ist Sieroter Milan; 1980 Sep; 59(4):366-73. PubMed ID: 7470278
[TBL] [Abstract][Full Text] [Related]
32. Immunological factors which influence response to immunotherapy in malignant melanoma.
Morton D; Eilber FR; Malmgren RA; Wood WC
Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
[TBL] [Abstract][Full Text] [Related]
33. Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum.
Theofilopoulos AN; Eisenberg RA; Dixon FJ
J Clin Invest; 1978 Jun; 61(6):1570-81. PubMed ID: 659616
[TBL] [Abstract][Full Text] [Related]
34. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
Hall RP; Lawley TJ; Heck JA; Katz SI
Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
[TBL] [Abstract][Full Text] [Related]
35. Experimental and clinical studies with active specific immunotherapy.
Livingston PO
Prog Clin Biol Res; 1989; 288():309-21. PubMed ID: 2654953
[TBL] [Abstract][Full Text] [Related]
36. Comparison of antibody isotypes in sera and circulating immune complexes during tumor growth and metastasis of three tumor models in mice.
McDonald TL; Collins M; Talmadge JE
Cancer Res; 1984 Nov; 44(11):4933-7. PubMed ID: 6435859
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes in sera of hamsters bearing simian virus 40-induced tumours.
Heimer R; de Vaux Saint Cyr C
Cancer Res; 1979 Aug; 39(8):2919-22. PubMed ID: 222437
[TBL] [Abstract][Full Text] [Related]
38. Demonstration of antibodies in patients' sera, directed against nonspecific cross-reacting antigen.
von Kleist S; King M; Havemann K
J Natl Cancer Inst; 1978 Dec; 61(6):1385-91. PubMed ID: 281546
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the role of circulating antigen-antibody complexes in the pathogenesis of glomerular nephropathies].
Favre H; Nydegger U; Zubler R; Mulli JC; Lambert PH; Cruchaud A
Schweiz Med Wochenschr; 1977 Dec; 107(48):1781-3. PubMed ID: 929139
[TBL] [Abstract][Full Text] [Related]
40. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden.
Morgan AC; Crane MM; Rossen RD
J Natl Cancer Inst; 1984 Feb; 72(2):243-9. PubMed ID: 6582312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
